CDH11 and cancer: The results from the in-house RT-qPCR, western blot, and IHC consistently supported the overexpression of CDH11 in OSCC tissues compared with non-cancer oral samples; these findings were further corroborated by differential expression analysis of globally gathered multi-center large samples (1225 OSCC samples and 413 non-cancer oral samples), ensuring the credibility of the analysis results in the present study.